Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Polestar Automotive Holding UK PLC Stock (PSNY) on Dec. 15, 2025: Reverse Split Aftermath, EU Policy Shockwaves, and the Latest Analyst Forecasts

Polestar Automotive Holding UK PLC Stock (PSNY) on Dec. 15, 2025: Reverse Split Aftermath, EU Policy Shockwaves, and the Latest Analyst Forecasts

Polestar Automotive Holding UK PLC (Nasdaq: PSNY) is back in the spotlight on December 15, 2025, and not because the EV market suddenly got calm. The Swedish electric performance brand has been navigating a rough stretch defined by Nasdaq listing pressure, cash-burn concerns across the EV sector, and now a major new wildcard: Europe’s potential rethink of its 2035 combustion-engine phaseout. As of Dec. 15, 2025, PSNY is quoted around $14.33, with recent trading ranges cited between $12.08 and $14.87 and a 52-week range of $11.75 to $42.60, depending on the data feed and timestamp. Investing.com That headline price is
15 December 2025
·····
Beyond Meat Stock (BYND) News, Forecasts, and Analyst Outlook — What Matters on December 15, 2025

Beyond Meat Stock (BYND) News, Forecasts, and Analyst Outlook — What Matters on December 15, 2025

Beyond Meat, Inc. (NASDAQ: BYND) is back in its “extreme volatility” era — except this time the fuel isn’t hype about the future of food. It’s a heady mix of heavy dilution, a reworked debt stack, meme-stock style trading dynamics, and a business still wrestling with weak demand. As of December 15, 2025, BYND was trading around $1.09. That dollar-and-change price tag is the headline — but it’s not the whole story. What really matters for investors following Beyond Meat stock right now is how the company’s balance-sheet rescue reshaped the share count, how soon the market could see additional
15 December 2025
····
ServiceNow Stock (NYSE: NOW) News Today: Armis Deal Talk, 5-for-1 Split Countdown, and Wall Street Forecasts (Dec. 15, 2025)

ServiceNow Stock (NYSE: NOW) News Today: Armis Deal Talk, 5-for-1 Split Countdown, and Wall Street Forecasts (Dec. 15, 2025)

ServiceNow (NYSE: NOW) is starting the week in the spotlight for three very different reasons: a fresh report that it’s nearing a potential $7 billion acquisition of cybersecurity firm Armis, a 5-for-1 stock split that’s set to kick in later this week, and an ongoing tug‑of‑war between bulls who see an “AI + workflow automation” powerhouse and skeptics who worry the market is still pricing in perfection. Reuters+1 As of early Dec. 15 trading, ServiceNow shares were around $865, modestly lower on the day. ServiceNow stock price action: where NOW stands heading into the split ServiceNow closed last week with
15 December 2025
·····
Applied Digital Corporation (APLD) Stock News, Forecasts and Analysis — What Investors Are Watching on Dec. 15, 2025

Applied Digital Corporation (APLD) Stock News, Forecasts and Analysis — What Investors Are Watching on Dec. 15, 2025

December 15, 2025 — Applied Digital Corporation (NASDAQ: APLD) has become one of the market’s most talked-about “picks-and-shovels” names in the AI boom: not a chipmaker, not a model builder, but a company racing to deliver the hard part of modern AI at scale—power-dense data centers. That positioning helped propel APLD sharply higher over 2025, but it also made the stock a magnet for volatility. Coming into mid-December, shares were hovering around the high-$20s, after a sharp one-day drop that reminded investors this is still a capital-intensive buildout story with real financing, execution, and tenant risks. StockAnalysis Below is a
15 December 2025
·····
Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health, Inc. (NYSE: OSCR) is back in the spotlight on December 15, 2025, as investors track a rare triple intersection of (1) U.S. health-policy headlines, (2) new analyst coverage and price-target resets, and (3) the most time-sensitive part of Affordable Care Act (ACA) open enrollment. As of the latest available market data, OSCR last traded around $16.63, with a market cap near $4.24 billion and a 52-week range of roughly $11.20 to $22.40. This is not a “set it and forget it” stock. Oscar is tightly linked to the economics of ACA marketplaces—and this week, the ACA story is
15 December 2025
····
Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi Stock (SAN.PA, SNY) Slides After Tolebrutinib Double Setback: FDA Delay, Trial Miss, and Fresh Analyst Forecasts (Dec. 15, 2025)

Sanofi stock is under pressure on December 15, 2025, after the French drugmaker disclosed two setbacks tied to its experimental multiple sclerosis (MS) medicine tolebrutinib—a regulatory delay in the U.S. for one progressive MS form and a failed Phase 3 endpoint in another. The update pushed Sanofi shares down about 4% in Paris trading, as investors recalibrated expectations for one of the company’s closely watched late-stage pipeline assets. Reuters+1 For U.S. investors watching the ADR, Sanofi (NASDAQ: SNY) traded around $48.68 at the latest timestamp available from market data in this session (10:15 UTC), modestly lower on the day. Below
15 December 2025
·····
Alibaba Stock (BABA) Today: Price, Latest News, Analyst Forecasts and 2026 Outlook as AI Spending Accelerates

Alibaba Stock (BABA) Today: Price, Latest News, Analyst Forecasts and 2026 Outlook as AI Spending Accelerates

December 15, 2025 — Alibaba Group Holding Limited (NYSE: BABA; HKEX: 9988) is heading into year-end with investors focused on one big question: can its aggressive AI-and-cloud push translate into durable profits before the bills for chips, data centers, and instant-delivery subsidies come due? As of Monday, Dec. 15, 2025, Alibaba’s U.S.-listed ADR was trading around $155.68. Below is a deep, current read of the main catalysts and risks shaping Alibaba stock right now—based on the most recent reporting and analyst updates available as of 15.12.2025. Alibaba stock price today: where BABA stands on Dec. 15, 2025 Alibaba’s ADR is
15 December 2025
······
New Fortress Energy (NFE) Stock Today (Dec. 15, 2025): Debt Deadline, Puerto Rico Contract, and Analyst Forecasts Collide

New Fortress Energy (NFE) Stock Today (Dec. 15, 2025): Debt Deadline, Puerto Rico Contract, and Analyst Forecasts Collide

December 15, 2025 — New Fortress Energy Inc. (NASDAQ: NFE) is back in the market spotlight as investors weigh a high-stakes mix of near-term debt pressure and fresh operating/contract progress. The stock traded around $1.26 in early data on Monday, down about 2.3% from the prior close. That price action isn’t happening in a vacuum. December 15 is also a date that shows up repeatedly in the company’s recent disclosures: it’s the end of a forbearance window tied to a missed interest payment—one of the central reasons NFE has been trading like a “headline-sensitive” distressed equity rather than a typical
15 December 2025
·····
WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

WORK Medical Technology Group LTD (NASDAQ: WOK) Stock: Today’s News, Nasdaq Compliance Risks, Dilution Watch, and Forecasts (Dec. 15, 2025)

December 15, 2025 — WORK Medical Technology Group LTD stock (Nasdaq: WOK) is back on traders’ radar as a hyper-volatile micro-cap with a story that reads like a corporate-actions speedrun: Nasdaq bid-price warnings, a 1-for-100 reverse stock split, rapid swings in market pricing, and fresh financing flexibility via an at-the-market (ATM) program. As of Dec. 15, 2025, market data platforms show WOK trading around $0.11, with a day range roughly $0.10–$0.15 and an eye-popping 52-week range of ~$0.10 to ~$624—a range that’s heavily distorted by the company’s reverse split and the way many platforms adjust historical prices. Investing.com+1 Below is
15 December 2025
·····
Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc. (NYSE: CLS; TSX: CLS) is back in the spotlight on December 15, 2025 after a sharp pullback that reminded investors of an uncomfortable truth: even “AI infrastructure winners” can get whipsawed when the market mood flips. On the NYSE, Celestica closed at $306.50 on December 12, down $44.91 (-12.78%), and was indicated higher in early pre-market trading on December 15 around $312.10 (+1.83%). StockAnalysis So what’s driving the move, what’s new in today’s news flow, and what do forecasts look like heading into 2026? Why Celestica stock dropped: the selloff was bigger than one company The most important
15 December 2025
······
ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Stock (NYSE: ZIM) in Focus: Takeover Bids, Proxy Fight, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

ZIM Integrated Shipping Services Ltd. stock is back in the spotlight on Dec. 15, 2025, caught at the intersection of three forces that can yank any shipping name around: freight-rate expectations, corporate control drama, and the always-contentious question of how much cash a cyclical carrier should return to shareholders. As of the latest available trading update, ZIM shares were around $18.76, down about 5.4% from the prior close—an intraday move that underscores how headline-sensitive the stock has become as takeover speculation heats up and a high-stakes shareholder vote approaches. ZIM Investors Why ZIM stock is moving now: M&A rumors collide
15 December 2025
······
Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) entered a new phase in its corporate life this month: from clinical-stage story stock to a company with an FDA-approved, commercially launchable cardiovascular product. The catalyst is CARDAMYST™ (etripamil) nasal spray, now approved in the U.S. for adults experiencing acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT)—a rapid heart rhythm disturbance that can be frightening, disruptive, and costly when it sends patients to emergency care. GlobeNewswire Yet in classic biotech fashion, the stock market’s reaction has been anything but simple. Despite the “yes” from regulators, MIST shares saw sharp volatility into the weekend, and investors
15 December 2025
·····
1 … 661 662 663 664 665 … 884

Stock Market Today

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Glencore share price steadies after Rio Tinto walks away — what to watch next week

Glencore share price steadies after Rio Tinto walks away — what to watch next week

7 February 2026
Glencore shares closed up 0.6% at 478.1 pence Friday, rebounding after a 7% drop following the collapse of merger talks with Rio Tinto. The company is expected to announce the sale of its Kazzinc stake soon and has signed a non-binding agreement with Orion for a potential $9 billion deal in the DRC. Investors await Glencore’s full-year results on Feb. 18 for further guidance.
Go toTop